Stocks
News
ETFs
Economy
Currencies
Press Releases
Articles from EOM Pharmaceuticals
EOM Pharmaceutical Holdings Reports Promising Preclinical Results and Provides an Update on EOM613 and EOM147
Clinical Trials in Cancer Cachexia, Inflammatory Bowel Disease and Retinal Disorders are Planned
By
EOM Pharmaceuticals
· Via
GlobeNewswire
· January 7, 2026
Articles from EOM Pharmaceuticals | The Union Democrat
